BROOKSNSEBrooks Laboratories Limited· PharmaceuticalsHighNeutral
Announced Fri, 29 May · 21:28 IST

Brooks Laboratories Limited has informed the Exchange regarding Appointment of Mr Prashant Rathi as Chief Executive Officer of the company w.e.f. Jun 01, 2026.

Management Changes View source PDF

BROOKS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+3.2%1-day move
₹65.29
prior close
₹68.55
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.8-1.5-0.0+0.0+3.2-0.4+0.9+0.8+2.6+4.5+7.2+10.7
Up moveDown movePending
AI summary

Brooks Laboratories Limited has appointed Mr. Prashant Rathi as Chief Executive Officer effective June 1, 2026. Notably, he will hold this role in addition to his existing position as Chief Financial Officer, making him a dual KMP (Key Managerial Personnel). Rathi is a Chartered Accountant and Company Secretary with over 13 years of experience in accounting and finance. He has been with Brooks Laboratories for more than five years and has developed a comprehensive understanding of the company's operations and financial systems. The appointment was based on the recommendation of the Nomination and Remuneration Committee and approved by the Board of Directors.

Likely market impact

This internal promotion combines two critical leadership roles (CEO and CFO) under one executive. While it ensures continuity and deep operational knowledge at the top, shareholders may watch whether holding dual roles impacts governance balance or workload management.